Pfizer | PFE - Current Liabilities



Pfizer reported $37.73B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
Abbott USD 13.44B 435M Jun/2025
ALKERMES USD 505.96M 62.23M Jun/2025
Amgen USD 20.48B 2.53B Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Drreddys Laboratories INR 142.59B 10.64B Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Glaxosmithkline GBP 20.38B 1.32B Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Medtronic USD 12.88B 1.04B Apr/2025
Merck USD 26.04B 863M Jun/2025
Neurocrine Biosciences USD 546.3M 23.4M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Novartis USD 31.71B 3.02B Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Perrigo USD 1.13B 52.3M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Prestige Brands USD 109.67M 3.04M Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
Sanofi 29.06B 103M Jun/2025
Vertex Pharmaceuticals USD 4.14B 355.2M Jun/2025
Zoetis USD 3.37B 19M Jun/2025